Kevin Buehler - 11 Apr 2022 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Director
Signature
/s/ Dario Scimeca, Attorney-in-Fact for Kevin Buehler
Issuer symbol
DTIL
Transactions as of
11 Apr 2022
Net transactions value
$0
Form type
4
Filing time
13 Apr 2022, 17:00:09 UTC
Previous filing
12 May 2021
Next filing
12 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Stock Option (Right to Buy) Award $0 +8,763 $0.000000 8,763 11 Apr 2022 Common Stock 8,763 $2.85 Direct F1
transaction DTIL Restricted Stock Units Award $0 +5,701 $0.000000 5,701 11 Apr 2022 Common Stock 5,701 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in 12 substantially equal monthly installments following April 11, 2022, such that the option shall be fully vested on April 11, 2023, subject to the Reporting Person continuing in service through each such vesting date.
F2 The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of the Company's Common Stock.
F3 The RSUs shall be fully vested on the first anniversary of the grant date of such RSUs, subject to the Reporting Person continuing in service through each such vesting date.